Abbvie Inc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Abbvie Inc with three other
companies in this sector in the United States:
Eli Lilly and Company
sales of $24.56 billion
of which 48%
was Human pharmaceutical products - Endocrin),
of which 56%
was Pharmaceuticals), and
of which 31%
was Vascular Products).
During the year ended December of 2018, sales at
Abbvie Inc were $32.75 billion.
increase of 16.1%
versus 2017, when the company's sales were $28.22 billion.
This was the fifth consecutive year of sales increases at Abbvie Inc
(and since 2013, sales have increased a total of 74%).